Researchers shed light on the immunometabolism of respiratory infection, providing an avenue towards safer COVID-19 therapeutics for those affected by metabolic disorders.
Antibody-drug conjugates deliver highly targeted killing power to tumor cells. Learn more about this emerging cancer therapy in this article from Sino Biological.
In situ hybridization has come a long way, now allowing researchers to characterize cells within the context of their tissue environments. Learn more about the spatial resolution revolution in this poster from 10x Genomics.
The Scientist Creative Services Team’s inbox is always open, so if you have questions or comments, we’d love to hear from you.
Never miss an email from The Scientist. Click hereto add The Scientist to your safe-sender list.
The Scientist,1000 N West Street, Suite 1200, Wilmington, Delaware, United States, 19801 Toll-Free: (888) 781-0328 | Phone: (705) 528-6888 Email: privacy@the-scientist.com
.jpg?upscale=true&width=1116&upscale=true&name=The%20Scientist%20-%20Immunology%20Special%20Topics%20Newsletter%20(1).jpg "The Next Generation of Cancer Immunotherapy")
.jpg?upscale=true&width=1116&upscale=true&name=The%20Scientist%20-%20Immunology%20Special%20Topics%20Newsletter%20(2).jpg "A Journey to the New Spatial Frontier")